Back to Search
LOGANATHAN ELANGOVAN, MD
MD
Nephrology Physician
NPI: 1477572881IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
40898-020(WI)
CMS Specialties
PrimaryNEPHROLOGY
Education
OTHER
Class of 1992
Research & Publications (4)
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
PMID 15112179·Am J Kidney Dis·2004
3-trial
A review of intravenous versus oral vitamin D hormone therapy in hemodialysis patients.
PMID 12779092·Clin Nephrol·2003
6-review
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.
PMID 11228177·Am J Kidney Dis·2001
3-trial
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.
PMID 10977787·Am J Kidney Dis·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1260 SENTRY DR STE 140
WAUKESHA, WI 53186 - Phone
- (262) 524-1024
Quick Facts
- NPI
- 1477572881
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 4
Are you this provider?
Claim Your Profile